Annie Waldman 3 months ago
The Center for Biologics Evaluation and Research, or CBER, was one of the hardest hit divisions.
It ensures the safety and quality of biological products for human use, like red blood cells, immunotherapy, and vaccines.
Since January, the center has lost about 500 people, or 26% of its workforce.